Raymond James & Associates’s Ellsworth Growth & Income Fund ECF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$229K Sell
25,462
-1,753
-6% -$15K ﹤0.01% 3559
2024
Q2
$224K Sell
27,215
-3,984
-13% -$31.9K ﹤0.01% 3543
2024
Q1
$253K Sell
31,199
-2,109
-6% -$16.9K ﹤0.01% 3478
2023
Q4
$269K Sell
33,308
-7,477
-18% -$57.7K ﹤0.01% 3349
2023
Q3
$328K Sell
40,785
-3,016
-7% -$25.8K ﹤0.01% 3154
2023
Q2
$377K Sell
43,801
-1,858
-4% -$15.1K ﹤0.01% 3106
2023
Q1
$370K Sell
45,659
-9,920
-18% -$84.2K ﹤0.01% 3105
2022
Q4
$444K Sell
55,579
-4,115
-7% -$34.5K ﹤0.01% 2981
2022
Q3
$478K Sell
59,694
-3,504
-6% -$32.1K ﹤0.01% 2888
2022
Q2
$538K Buy
63,198
+5,406
+9% +$50.5K ﹤0.01% 2874
2022
Q1
$612K Sell
57,792
-5,070
-8% -$54.9K ﹤0.01% 2939
2021
Q4
$777K Sell
62,862
-20,409
-25% -$268K ﹤0.01% 2791
2021
Q3
$1.11M Sell
83,271
-25,461
-23% -$369K ﹤0.01% 2504
2021
Q2
$1.6M Buy
108,732
+6,683
+7% +$94.8K ﹤0.01% 2256
2021
Q1
$1.38M Sell
102,049
-19,854
-16% -$289K ﹤0.01% 2282
2020
Q4
$1.69M Buy
121,903
+6,500
+6% +$81.8K ﹤0.01% 1994
2020
Q3
$1.33M Sell
115,403
-42,751
-27% -$511K ﹤0.01% 2004
2020
Q2
$1.82M Sell
158,154
-4,108
-3% -$42.5K ﹤0.01% 1790
2020
Q1
$1.39M Sell
162,262
-21,258
-12% -$229K ﹤0.01% 1774
2019
Q4
$2.16M Sell
183,520
-2,093
-1% -$23.1K ﹤0.01% 1777
2019
Q3
$1.95M Sell
185,613
-1,314
-0.7% -$14K ﹤0.01% 1789
2019
Q2
$1.92M Sell
186,927
-2,737
-1% -$26.7K ﹤0.01% 1828
2019
Q1
$1.82M Sell
189,664
-8,808
-4% -$82.1K ﹤0.01% 1824
2018
Q4
$1.71M Sell
198,472
-14,061
-7% -$127K ﹤0.01% 1762
2018
Q3
$2.19M Buy
212,533
+17,856
+9% +$176K ﹤0.01% 1753
2018
Q2
$1.84M Buy
194,677
+6,530
+3% +$60.9K ﹤0.01% 1800
2018
Q1
$1.72M Sell
188,147
-8,394
-4% -$78.3K ﹤0.01% 1796
2017
Q4
$1.85M Sell
196,541
-39,892
-17% -$371K ﹤0.01% 1741
2017
Q3
$2.19M Buy
236,433
+14,722
+7% +$135K ﹤0.01% 1586
2017
Q2
$2.03M Buy
221,711
+21,136
+11% +$189K ﹤0.01% 1570
2017
Q1
$1.73M Buy
200,575
+35,363
+21% +$302K ﹤0.01% 1613
2016
Q4
$1.37M Buy
165,212
+48,973
+42% +$397K ﹤0.01% 1747
2016
Q3
$952K Buy
116,239
+13,931
+14% +$115K ﹤0.01% 1919
2016
Q2
$806K Buy
102,308
+17,126
+20% +$132K ﹤0.01% 1856
2016
Q1
$647K Buy
85,182
+6,981
+9% +$50.7K ﹤0.01% 1915
2015
Q4
$606K Buy
78,201
+3,578
+5% +$28.4K ﹤0.01% 1888
2015
Q3
$584K Hold
74,623
﹤0.01% 1859
2015
Q2
$659K Buy
74,623
+550
+0.7% +$4.97K ﹤0.01% 1948
2015
Q1
$649K Buy
74,073
+1,558
+2% +$13.4K ﹤0.01% 1907
2014
Q4
$632K Buy
72,515
+8,629
+14% +$73.2K ﹤0.01% 1840
2014
Q3
$553K Sell
63,886
-7,350
-10% -$64.8K ﹤0.01% 1814
2014
Q2
$629K Buy
71,236
+2,491
+4% +$21.4K ﹤0.01% 1740
2014
Q1
$591K Buy
68,745
+35,247
+105% +$295K ﹤0.01% 1707
2013
Q4
$274K Buy
33,498
+2,883
+9% +$23.1K ﹤0.01% 1876
2013
Q3
$241K Buy
30,615
+2,698
+10% +$21K ﹤0.01% 1852
2013
Q2
$214K Buy
+27,917
New +$216K ﹤0.01% 1832

Other funds holding ECF

Raymond James & Associates's ECF Position: Q3 2024 in Review

Raymond James & Associates reduced its Ellsworth Growth & Income Fund (ECF) stake by 6.4% in Q3 2024, selling an estimated $15K and leaving 25,462 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #3559.

Raymond James & Associates first reported a position in ECF in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.19M in Q3 2018. 58 funds tracked by Wall St. Rank hold ECF as of Q3 2024.

  • Raymond James & Associates held 25,462 shares of Ellsworth Growth & Income Fund worth $229K as of Q3 2024.
  • Raymond James & Associates sold 1,753 Ellsworth Growth & Income Fund shares in Q3 2024, an estimated $15K.
  • Ellsworth Growth & Income Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3559 holding.
  • Raymond James & Associates first reported a position in Ellsworth Growth & Income Fund in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Ellsworth Growth & Income Fund position peaked at $2.19M in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Ellsworth Growth & Income Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.